【摘要】 摘要:目的:通过230例原发性肝癌的介入治疗,研究其疗效及影响因素。材料与方法:回顾性分析230例肝癌肝动脉化疗、栓塞的临床随访资料。结果:总疗效为症状缓解占69.1％,肿瘤缩小占62.6％,AFP下降44.8％。半年、1、2、3年生存率分别为80.9％、51.3％、30％、18.7％。对比分析了肿瘤的大小、门脉癌栓的有无及治疗方法等影响疗效的有关因素。结论:肝癌的介入治疗疗效明显优于其他非手术疗法,早中期、单个肿瘤、直径<10cm、无门脉癌栓或肝动静脉瘘、治疗2次以上及栓塞完全者,疗效明显优于对应组。综合治疗将会进一步提高肝癌化疗栓塞的疗效。更多还原

【Abstract】 Objectives: For interventional therapy in primary Hepatocellular carcinoma (HCC), The therapeutic effects, and its influence factors were evaluated. Materials and Methods: Follow-up data of 230 patients with HCC after hepato-arterial-chemoembolization were reviewed. Results: Total effects included Relief of sympotoms (69.1 % ) : shrinkage of tumor (62.6%): AFP decreasing (44.8%): half year,1,2,3 years survival rates were 80. 9% ,51. 3% ,30% ,18. 7% respectively. The therapeutic methods and the factors involving treatment effects were analysed comparatively. Conclusion: Interventional treatment of liver canaer was much better than those of non-operative methods. In the cases of early/middle stage, single lesion, the diameter of tumor< 10cm, no cancer embolus in portal vein, no hepato-arterial-venous fistula, more than 2 times of hemoembolization, and complete em-bolization of tumor, the therapeutic effect would be superior to the corresponding group. The comprehensive treafment loould impwve the therapeutic effect of hepato-chemoem-bolization.更多还原